Nyxoah (NYXH) has released an update.
Nyxoah SA, a medical tech company specializing in OSA treatments, has closed its public offering in the U.S., raising approximately $52.5 million before expenses. The funds will support U.S. commercial activities, clinical data collection, research, and general corporate purposes. Cantor Fitzgerald & Co. served as the sole book-running manager with Degroof Petercam as co-manager for the offering.
For further insights into NYXH stock, check out TipRanks’ Stock Analysis page.
